| Secondary |
| Drug Use For Unknown Indication |
48.9% |
| Product Used For Unknown Indication |
26.9% |
| Hypertension |
3.0% |
| Prostate Cancer |
3.0% |
| Suicide Attempt |
2.4% |
| Atrial Fibrillation |
2.2% |
| Myocardial Infarction |
2.2% |
| Completed Suicide |
1.8% |
| Atrial Flutter |
1.2% |
| Antiinflammatory Therapy |
1.0% |
| Mitral Valve Prolapse |
1.0% |
| Blood Pressure |
0.8% |
| Colorectal Cancer Metastatic |
0.8% |
| Essential Hypertension |
0.8% |
| Type Ii Diabetes Mellitus |
0.8% |
| Agitation |
0.6% |
| Analgesic Therapy |
0.6% |
| Cerebrovascular Accident |
0.6% |
| Drug Therapy |
0.6% |
| Migraine |
0.6% |
|
| Completed Suicide |
30.4% |
| Poisoning |
17.8% |
| Death |
12.6% |
| Dizziness |
3.7% |
| Vomiting |
3.7% |
| Intentional Drug Misuse |
3.0% |
| Overdose |
3.0% |
| Suicide Attempt |
3.0% |
| Drug Abuse |
2.2% |
| Intentional Overdose |
2.2% |
| Muscular Weakness |
2.2% |
| Premature Labour |
2.2% |
| Rash |
2.2% |
| Respiratory Arrest |
2.2% |
| Tachycardia |
2.2% |
| Alpha 1 Microglobulin Increased |
1.5% |
| Atrial Flutter |
1.5% |
| Drug Ineffective |
1.5% |
| Duodenal Ulcer |
1.5% |
| Feeling Abnormal |
1.5% |
|
| Concomitant |
| Hypertension |
30.5% |
| Product Used For Unknown Indication |
21.2% |
| Type 2 Diabetes Mellitus |
7.7% |
| Diabetes Mellitus |
7.2% |
| Drug Use For Unknown Indication |
5.9% |
| Atrial Fibrillation |
5.2% |
| Pain |
2.5% |
| Coronary Artery Disease |
2.2% |
| Acute Myocardial Infarction |
1.9% |
| Depression |
1.9% |
| Osteoporosis |
1.8% |
| Peritoneal Dialysis |
1.8% |
| Dyslipidaemia |
1.7% |
| Cardiac Failure |
1.5% |
| Arteriosclerosis |
1.4% |
| Multiple Myeloma |
1.3% |
| Hypercholesterolaemia |
1.2% |
| Schizophrenia |
1.1% |
| Hyperlipidaemia |
1.0% |
| Pulmonary Arterial Hypertension |
1.0% |
|
| Atrial Fibrillation |
9.8% |
| Death |
9.2% |
| Myocardial Infarction |
6.9% |
| Dyspnoea |
6.3% |
| Cardiac Failure |
5.8% |
| Hypertension |
5.5% |
| Urine Albumin/creatinine Ratio Increased |
5.5% |
| Hypertensive Crisis |
5.2% |
| Renal Failure |
4.9% |
| Syncope |
4.9% |
| Weight Increased |
4.6% |
| Vomiting |
4.3% |
| Angina Pectoris |
3.7% |
| Acute Myocardial Infarction |
3.5% |
| Pyrexia |
3.5% |
| Renal Failure Acute |
3.5% |
| Stent Placement |
3.5% |
| Cardiac Failure Congestive |
3.2% |
| Coronary Artery Disease |
3.2% |
| Coronary Artery Stenosis |
3.2% |
|
| Interacting |
| Blood Pressure |
64.0% |
| Hypertension |
12.0% |
| Urinary Incontinence |
12.0% |
| Anxiety |
8.0% |
| Oestrogen Replacement Therapy |
4.0% |
|
| Tremor |
60.0% |
| Drug Interaction |
20.0% |
| Ventricular Extrasystoles |
20.0% |
|
